BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/14/2026 10:14:03 AM | Browse: 18 | Download: 3
Publication Name World Journal of Hepatology
Manuscript ID 124884
DOI 10.4254/wjh.124884
Country China
Category Immunology
Manuscript Type Minireviews
Article Title From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B
Manuscript Source Invited Manuscript
All Author List Bing Tian, Chen Tian, Chuan-Lai Shen and Qun Zhang
Funding Agency and Grant Number
Funding Agency Grant Number
Jiangsu Province High-Level Hospital Construction Funds of Zhongda Hospital, School of Medicine, Southeast University 2024GSPKY23
Chinese Foundation for Hepatitis Prevention and Control Muxin research fund of CHB MX202413
Corresponding Author Qun Zhang, MD, PhD, Department of Infectious Diseases, Zhongda Hospital, Southeast University, 87 Ding Jia Qiao, Nanjing 210009, Jiangsu Province, China. slim888@163.com
Key Words Chronic hepatitis B; Hepatitis B virus-specific T cells; Pegylated interferon; Functional cure; Immune stratification
Core Tip Currently, patient selection for pegylated interferon (PEG-IFN) therapy predominantly relies on virological markers, which fail to fully recapitulate host immune competence. This review highlights that hepatitis B virus-specific T cells constitute core immune biomarkers predictive of treatment response and functional cure. Synthesizing available evidence concerning T cell exhaustion, regenerative potential, effector function and comprehensive immune profiling, we propose that future patient selection algorithms should transition from virology-only criteria toward immune stratification strategies. This conceptual framework underpins the development of precision PEG-IFN therapy for chronic hepatitis B.
Citation Tian B, Tian C, Shen CL, Zhang Q. From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B. World J Hepatol 2026; In press
PDF 124884-in-press.pdf
Received
2026-07-01 00:13
Peer-Review Started
2026-07-01 00:13
First Decision by Editorial Office Director
Return for Revision
2026-07-22 05:52
Revised
2026-07-31 12:25
Publication Fee Transferred
Second Decision by Editor
2026-08-13 02:29
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-08-14 10:14
Articles in Press
2026-08-14 10:14
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5182 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com